Summary Translation of Loan AgreementLoan Agreement • July 29th, 2016 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
iKang Healthcare Technology Group Co., Ltd. (the “Borrower”) and AVIC Trust Co., Ltd. (the “Lender”) entered into the Loan Agreement (the “Agreement”) on December 9, 2015.
Summary Translation of Investment AgreementInvestment Agreement • July 29th, 2016 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
Shenzhen Xingwang Great Health No.1 Investment Center (Limited Partnership) (“Party A”) and iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) entered into the Investment Agreement on December 7, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016.
Summary Translation of Investment AgreementTranslation of Investment Agreement • July 29th, 2016 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
Zhongjin Zhide Equity Investment Management Co., Ltd. (“Party A”) and iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) entered into the Investment Agreement on December 11, 2015.
Summary Translation of Investment AgreementInvestment Agreement • July 29th, 2016 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
Tianjin Junlian Yunpeng Enterprise Management Consulting Partnership (Limited Partnership) (“Party A”), iKang Healthcare Technology Group Co., Ltd. (“Party B”, or the “Company”) and Beijing Junlian Xinhai Equity Investment Partnership (Limited Partnership) (“Party C”) entered into the Investment Agreement on December 30, 2015, as supplemented by the Supplemental Agreement to the Investment Agreement dated February 14, 2016.
Summary Translation of Capital Injection AgreementCapital Injection Agreement • July 29th, 2016 • iKang Healthcare Group, Inc. • Services-offices & clinics of doctors of medicine
New China Life Insurance Co., Ltd. (“NCI”), iKang Guobin Healthcare Group Co., Ltd. (“iKang”), Shenzhen Top Spring Pu Chang Investment Management Co., Ltd. (“Top Spring Pu Chang”) and New China Life Insurance Health Investment Management Co., Ltd. (the “Target Company”) entered into the Capital Injection Agreement (the “Agreement”) on December 4, 2015, as supplemented by the Supplemental Agreement to the Capital Injection Agreement dated January 22, 2016.
